SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2012 07:00

RNS Number : 4867Q
Spirax-Sarco Engineering PLC
07 November 2012
 



News Release

 

Wednesday 7th November 2012

INTERIM MANAGEMENT STATEMENT

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st July 2012 to 6th November 2012.

 

Trading

In the four months ended 31st October, organic sales increased 6%, ahead of the rate of growth reported in the first half year. Notably, Asia Pacific and Watson-Marlow achieved strong double-digit sales growth in the period, followed by a more modest advance in the Americas and slightly reduced sales in our Europe, Middle East and Africa (EMEA) segment. Sales in sterling were ahead 2% in the first ten months of 2012, after including the impact of unfavourable currency movements and two small disposals last year.

 

As anticipated, our trading performance in the four months ended 31st October improved with operating profit 8% ahead at constant currency. Better results were particularly evident in Watson-Marlow, where the planned increases in R&D and market development costs in the first half year are unwinding in the second half. Results also improved in EMEA, as the cost base in Europe is being progressively lowered and the profitability of our Supply operations increased. For the ten months ended 31st October 2012, operating profit was therefore 2% ahead of last year at constant currency, compared with a decline of 3% for the first half year.

 

Financial position

We continue to operate with a strong balance sheet and are steadily reducing and rebalancing our stock position in Europe, although this continues to have a negative impact on the factory loading in our main manufacturing plants in the UK and France. Net cash balances at the end of October 2012 increased to £43m compared with £9m at 30th June 2012, although the interim dividend of £12m will be paid on 9th November. There were no significant events or transactions during the period that resulted in a material impact on the financial position of the Group. The principal risks and uncertainties remain those set out on pages 26 and 27 of the 2011 Annual Report.

 

Outlook

Global macro-economic conditions have weakened in recent months as reflected in slowing rates of GDP growth and industrial output in most geographic regions. Trading conditions in many of our markets have, however, remained more resilient and we have not seen softening in underlying demand. The Group has a favourable weighting to defensive industries such as food & beverage, pharmaceuticals and health care, and maintenance spending by our customers has continued to be positive, even against the deterioration in economic conditions.

 

Our business has other resilient characteristics due to our diverse geographic, industry, customer and product spread, and the large proportion of our sales that derive from maintenance or operating spend by our customers. We are seeing the improvements in our Supply organisation from the site consolidation in the UK and from the previously announced cost reduction programme in Europe, which should be complete by the year-end.

 

Although our forward visibility remains short and we are not immune to a worsening in our markets, which can be reflected fairly quickly in our mid-cycle business, the Board continues to expect the Group to make progress for the full year.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

Note

All references above are to adjusted trading results that exclude non-operational items, including the previous announced restructuring costs, amortisation of acquisition-related intangible assets and acquisition and disposal costs.

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBUGGBGDL
Date   Source Headline
25th Nov 200512:22 pmRNSHolding(s) in Company
17th Nov 200510:00 amRNSAdditional Listing
11th Nov 20055:03 pmRNSDirector/PDMR Shareholding
10th Nov 20053:48 pmRNSDirector/PDMR Shareholding
26th Oct 20054:18 pmRNSDirector/PDMR Shareholding
12th Oct 20053:40 pmRNSAdditional Listing
11th Oct 200511:00 amRNSDirector/PDMR Shareholding
7th Oct 20051:56 pmRNSDirector/PDMR Shareholding
4th Oct 20059:55 amRNSDirector/PDMR Shareholding
30th Sep 20054:22 pmRNSDirector/PDMR Shareholding
9th Sep 20055:11 pmRNSDirector/PDMR Shareholding
9th Sep 20054:17 pmRNSDirector/PDMR Shareholding
6th Sep 20057:00 amRNSInterim Results
4th Aug 200511:31 amRNSHolding(s) in Company
2nd Aug 200510:33 amRNSNotice of Results
28th Jul 20054:46 pmRNSHolding(s) in Company
12th Jul 20059:30 amRNSIFRS Statement
28th Jun 20055:10 pmRNSAdditional Listing
27th Jun 200510:20 amRNSAcquisition
24th Jun 20053:50 pmRNSDirector Shareholding
20th Jun 20055:13 pmRNSDirector Shareholding
9th Jun 20051:56 pmRNSAcquisition
27th May 200512:34 pmRNSAdditional Listing
26th May 20058:30 amRNSDirector Shareholding
25th May 20055:11 pmRNSDirector Shareholding
24th May 20054:54 pmRNSDirector Shareholding
20th May 20055:26 pmRNSDirector Shareholding
12th May 20052:10 pmRNSAGM Statement
29th Apr 20054:25 pmRNSDirector Shareholding
26th Apr 200511:11 amRNSHolding(s) in Company
18th Apr 20055:50 pmRNSHolding(s) in Company
4th Apr 20054:03 pmRNSAdditional Listing
29th Mar 20053:40 pmRNSDirector Shareholding
24th Mar 200511:26 amRNSDirector Shareholding
23rd Mar 20055:23 pmRNSDirector Shareholding
17th Mar 20054:56 pmRNSDirector Shareholding
14th Mar 20054:32 pmRNSDirector Shareholding
14th Mar 20057:00 amRNSFinal Results
25th Feb 20054:29 pmRNSHolding(s) in Company
16th Feb 20051:55 pmRNSBoard Membership Changes
17th Jan 20055:19 pmRNSHolding(s) in Company
12th Jan 20059:15 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.